Adverse Reactions (6.1).] Maintenance of JANUVIA During Initiation and Titration of Insulin Glargine A total of 746 patients with type 2 diabetes (mean baseline HbA1C 8.8%, disease duration 10.8 years) participated in a 30-week, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of continuing JANUVIA during the initiation and uptitration of insulin glargine
Around 15% of youth with a single autoantibody detected and no symptoms will go on to develop T1D
Access is limited to regulated, medically supervised pathways , makHomeing it essential to separate online discussion from reality
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Titration (3 mL = ~3.33 mg/mL) Subcutaneous injection, once daily
It is well established that overweight and obesity increase a persons risk of cardiovascular events, but the concept of treating obesity to reduce cardiovascular complications has been hampered by lack of evidence that lifestyle or pharmacologic interventions for overweight or obesity improve cardiovascular outcomes, says Dr
Individuals with diabetes are at particularly high risk of NAFLD, theorized to be due to excess energy driving insulin resistance seen in diabetes resulting in increased uptake of free fatty acids in the liver